Study examines risk factors for cancer in unaffected breast of breast cancer patients

	Tweet

A new study identifies certain patient and tumor characteristics that may help indicate which breast cancer patients would be the most likely to benefit from preventive surgery to remove the unaffected breast. Published in the March 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study could help patients with breast cancer make more informed treatment choices.

Women diagnosed with breast cancer are known to be at increased risk of developing breast cancer in the opposite breast, either at the time of diagnosis or some time in the future. Identifying which women are most at risk of cancer in the other breast could help patients decide whether to have preventive treatment, including mastectomy to remove the unaffected breast. While a fairly drastic measure, some women may choose this option due to a variety of factors, such as advice from their physician, fear of another breast cancer diagnosis, desire for cosmetic symmetry and family history of breast or other cancers.

While most breast cancer patients would not experience any survival benefit from such a contralateral prophylactic mastectomy, it is difficult to determine which patients should consider the procedure. If physicians could predict which patients are at the highest risk of developing contralateral breast cancer and which are not, many patients could preserve their unaffected breast if desired.

To identify the factors that predict contralateral breast cancer, Dr. Kelly K. Hunt and colleagues at the University of Texas M. D. Anderson Cancer Center in Houston studied 542 patients who had breast cancer in one breast and who had both breasts removed between 2000 and 2007.

From the prophylactic mastectomy specimen, the researchers found that twenty-five patients (5 percent) had contralateral breast cancer, and 82 patients (15 percent) had cells in the other breast that were abnormal and could signify higher risk for breast cancer development.

When the investigators looked for clinical features associated with contralateral breast cancer, they found three independent factors: when the cancer cells had certain histologic invasive characteristics; when the cancer was present in more than one quadrant of the breast; and when the patient had a 5-year Gail risk of 1.67 percent or greater. The Gail model is a breast cancer risk assessment tool used for women without a cancer diagnosis that takes into consideration a woman’s medical history, age, race and other characteristics.

Also, women aged 50 years or older at the initial cancer diagnosis or who had additional moderate- to high-risk cells in their affected breast were likely to have abnormal cells in the other breast that could potentially develop into cancer.

###

Article: “Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.” Min Yi, Funda Meric-Bernstam, Lavinia P. Middleton, Banu K. Arun, Isabelle Bedrosian, Gildy V. Babiera, Rosa F. Hwang, Henry M. Kuerer, Wei Yang, and Kelly K. Hunt. CANCER; Published Online: January 26, 2009 (DOI: 10.002/cncr.24129); Print Issue Date: March 1, 2009.

Contact: David Sampson

American Cancer Society

RELATED STORIES:
Radiation rates for breast cancer may be underestimated, U-M study finds   Teaching Breast Health Early to Reduce Breast Cancer Mortality in D.C.   New breast cancer gene raises risk in Europeans   Hispanic Women and Breast Cancer: An Understudied Group   Breast cancer may be on the rise in U.S.-based Latinas   Why Do Some Women Develop Breast Cancer Earlier Than Others?   US panel mulls minimum breast cancer hospital stay   New approach to treating breast cancer uses existing chemo drug   Novel methods for improved breast cancer survival   Relapse Still a Real Possibility for Breast Cancer Patients   New Peptide Could be Effective Treatment for Triple Negative Breast Cancer   MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis   Reconstruction surgery rarely discussed with breast cancer patients   Lilly bone drug cuts breast cancer risk - study   Low-dose radiation may raise breast cancer risk   Lobular breast cancer can be managed as ductal cancer   New Guideline Will Improve Hormone Receptor Testing for Patients with Breast Cancer   ACE Inhibitors May Increase Risk of Recurrence in Breast Cancer Survivors   Inflammation Markers Identify Fatigue in Breast Cancer Survivors   Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer   Reflexology helps women with breast cancer cope   Hair relaxers do not increase risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]